Clinical Trials

Uterine Cervical Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

120 enrolled

Uterine Cervical Neoplasms

NCT01247779 2026-03-13

ROBO-GYN

386 enrolled

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT01641484 2026-03-13

ANOXICOL

Phase NA Terminated

9 enrolled

Uterine Cervical Neoplasms, Neoplasms

NCT03315351 2026-03-13

TEP-Curie

14 enrolled

Phase 1/2 Active not recruiting

Uterine Cervical Neoplasms

NCT03786081 2026-03-13

Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer

214 enrolled

Phase NA Active not recruiting

Uterine Cervical Neoplasms

NCT04266886 2026-03-13

Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer

152 enrolled

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT05521997 2026-03-13

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

42 enrolled

Uterine Cervical Neoplasms

NCT06459180 2026-03-13

TroFuse-020

Phase 3 Recruiting

686 enrolled

Uterine Cervical Neoplasms

NCT07216703 2026-03-13

TroFuse-036

Phase 3 Recruiting

1,023 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT07471113 2026-03-13

Mobile App-Supported HPV and Breast Cancer Awareness Program

70 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

NCT04300647 2026-03-12

SKYSCRAPER-04

Phase 2 Completed

172 enrolled 27 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Uterine Cervical Neoplasms

NCT05269381 2026-03-12

PNeoVCA

Phase 1/2 Recruiting

132 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05758688 2026-03-12

PROPS GYN

Phase 2 Recruiting

25 enrolled

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT06952660 2026-03-12

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Phase 4 Recruiting

100 enrolled

Phase NA Not yet recruiting

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT07466901 2026-03-12

A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer

30 enrolled

Uterine Cervical Neoplasms

NCT03968406 2026-03-11

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Phase 1 Recruiting

24 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT07461818 2026-03-11

POC

5,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04341883 2026-03-10

Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer

Phase 2 Completed

27 enrolled

Uterine Cervical Neoplasms

NCT04651127 2026-03-10

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Phase 1/2 Terminated

5 enrolled

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT05824468 2026-03-10

Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer

30 enrolled

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Uterine Cervical Neoplasms

NCT07229313 2026-03-10

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

76 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06142760 2026-03-09

AIM-C1

40 enrolled

BreastGenitourinaryGynecologic

Uterine Cervical Neoplasms

NCT06533059 2026-03-09

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

Phase 1 Recruiting

110 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07202364 2026-03-09

A Study of YL202 in Patients With Advanced Solid Tumors

Phase 2 Recruiting

100 enrolled

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Colorectal Neoplasms

NCT00188539 2026-03-06

Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels

Phase 2 Active not recruiting

346 enrolled

Uterine Cervical Neoplasms

NCT00900575 2026-03-06

Cervical Cancer Detection Using Optical Spectroscopy

350 enrolled

Uterine Cervical Neoplasms

NCT04107181 2026-03-06

Calla

305 enrolled

Uterine Cervical Neoplasms

NCT07120945 2026-03-06

Embrace Gyn

GynecologicOther neoplasm

70 enrolled

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

NCT07453459 2026-03-06

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

Phase NA Not yet recruiting

100 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03853915 2026-03-05

HPVDNA02

64 enrolled

Uterine Cervical Neoplasms

NCT05035173 2026-03-04

LYSA

BreastGastrointestinalGenitourinaryGynecologicSarcoma

200 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06760819 2026-03-04

panSOHO

Phase 2 Recruiting

111 enrolled

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors

NCT07447895 2026-03-04

Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

Phase NA Not yet recruiting

28 enrolled

Uterine Cervical Neoplasms, Pelvic Floor Disorders

NCT06968871 2026-03-03

Ameliorated Pap Tests and Cervical Cancer Screening Participation

248 enrolled

Uterine Cervical Neoplasms, Pain

NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Phase NA Withdrawn

Phase 2 Not yet recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

180 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT05108298 2026-03-02

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials